Request Sample Inquiry
Allergy Diagnostics Market

Allergy Diagnostics Market

Allergy Diagnostics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

150

Base Year:

2022

Date

Mar - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1367

Segments Covered
  • By Product & Service By Product & Service Consumables, Instruments, Immunoassay Analyzers, ELISA Analyzers, Luminometers, Services, Other Instruments
  • By Allergen By Allergen Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens
  • By Test Type By Test Type In Vivo Tests, Skin Prick Tests, Patch Tests, In Vivo Tests, Other In Vitro Tests
  • By End User By End User Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 5327.20 Million
Revenue 2030Revenue 2030: USD 11841.27 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 10.50%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Allergy Diagnostics Market by Product & Service by Allergen by Test Type by End User - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

The next stage involves the primary research conducted to gather further information and revalidate the data collected from the secondary research. Moreover, primary research is also conducted to identify key players in the market and to gather their market-specific financial information. A typical primary interview fulfills data requirements pertaining to first-hand information global market size, regional and segmental trends, competitive landscape expertise development and market understandings among others. 

Data Triangulation and Market Size Estimations

Top-down and bottom-up approaches are used to validate and estimate the market size of the Allergy Diagnostics market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. The data was triangulated by employing various data models and statistical techniques to arrive at exact statics and market size for each segment/sub-segment of the market.  

FAQ
Frequently Asked Question
  • The global Allergy Diagnostics valued at USD 5327.20 Million in 2022 and is expected to reach USD 11841.27 Million in 2030 growing at a CAGR of 10.50%.

  • The prominent players in the market are Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK)..

  • The market is project to grow at a CAGR of 10.50% between 2023 and 2030.

  • The driving factors of the Allergy Diagnostics include

    • increasing environmental pollution globally and the increasing access to healthcare insurance

  • North America was the leading regional segment of the Allergy Diagnostics in 2022.